These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38444134)

  • 1. [Research progress of trace amine-associated receptor 1 signaling pathways].
    Sun M; Zhang CC; Li JT; Si TM; Su YA
    Sheng Li Xue Bao; 2024 Feb; 76(1):89-96. PubMed ID: 38444134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAAR1 as an emerging target for the treatment of psychiatric disorders.
    Liu J; Wu R; Li JX
    Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress on the immunomodulatory effects and mechanisms of trace amine-associated receptor 1].
    Zhang XQ; Li JT; Si TM; Su YA
    Sheng Li Xue Bao; 2023 Apr; 75(2):248-254. PubMed ID: 37089099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace amine-associated receptor 1 as a monoaminergic modulator in brain.
    Xie Z; Miller GM
    Biochem Pharmacol; 2009 Nov; 78(9):1095-104. PubMed ID: 19482011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
    Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
    Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAAR Agonists.
    Xu Z; Li Q
    Cell Mol Neurobiol; 2020 Mar; 40(2):257-272. PubMed ID: 31848873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.
    Leo D; Targa G; Espinoza S; Villers A; Gainetdinov RR; Ris L
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.
    Wu R; Li JX
    CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
    Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
    Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.
    Pei Y; Asif-Malik A; Canales JJ
    Front Neurosci; 2016; 10():148. PubMed ID: 27092049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
    Revel FG; Moreau JL; Gainetdinov RR; Bradaia A; Sotnikova TD; Mory R; Durkin S; Zbinden KG; Norcross R; Meyer CA; Metzler V; Chaboz S; Ozmen L; Trube G; Pouzet B; Bettler B; Caron MG; Wettstein JG; Hoener MC
    Proc Natl Acad Sci U S A; 2011 May; 108(20):8485-90. PubMed ID: 21525407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
    Xie Z; Westmoreland SV; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trace amine-associated receptor 1 and drug abuse.
    Wu R; Liu J; Li JX
    Adv Pharmacol; 2022; 93():373-401. PubMed ID: 35341572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics.
    Revel FG; Moreau JL; Gainetdinov RR; Ferragud A; Velázquez-Sánchez C; Sotnikova TD; Morairty SR; Harmeier A; Groebke Zbinden K; Norcross RD; Bradaia A; Kilduff TS; Biemans B; Pouzet B; Caron MG; Canales JJ; Wallace TL; Wettstein JG; Hoener MC
    Biol Psychiatry; 2012 Dec; 72(11):934-42. PubMed ID: 22705041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vivo pharmacology of Trace-Amine Associated Receptor 1.
    Lam VM; Espinoza S; Gerasimov AS; Gainetdinov RR; Salahpour A
    Eur J Pharmacol; 2015 Sep; 763(Pt B):136-42. PubMed ID: 26093041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
    Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
    Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trace Amines and Their Receptors.
    Gainetdinov RR; Hoener MC; Berry MD
    Pharmacol Rev; 2018 Jul; 70(3):549-620. PubMed ID: 29941461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
    Xie Z; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of Trace Amines in the Brain-Gut-Microbiome Axis via Trace Amine-Associated Receptor-1 (TAAR1).
    Bugda Gwilt K; González DP; Olliffe N; Oller H; Hoffing R; Puzan M; El Aidy S; Miller GM
    Cell Mol Neurobiol; 2020 Mar; 40(2):191-201. PubMed ID: 31836967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists.
    Kleinau G; Pratzka J; Nürnberg D; Grüters A; Führer-Sakel D; Krude H; Köhrle J; Schöneberg T; Biebermann H
    PLoS One; 2011; 6(10):e27073. PubMed ID: 22073124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.